[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association
EPDA - European Parkinsons Disease Association
REWRITE TOMORROW
.

Treatment and management

There is no single specific treatment for PSP and, because it is a complex illness, a combination of approaches will probably be suggested:

Supportive therapies - early referral is generally recommended to the various members of the multidisciplinary team (MDT) who can help with specific difficulties.  It is important to communicate with your doctor so that he or she can put you in touch with the right, experienced professionals.  Depending on the country in which you live, an occupational therapist or physiotherapist will be able to provide gait assessment and suggest equipment and strategies to help.  A speech and language therapist will be able to advise on overcoming difficulties in with speech, swallowing and eating and should be a core member of the MDT care for a person with PSP.  See also Who can help?

Feeding - over time there is an increased risk of complications such as pneumonia, including aspiration pneumonia due to an inability to swallow.  Where swallow becomes too difficult, it may be necessary to introduce a feeding or PEG tube – for more information see Speech and language therapy treatments.

Medication – few medications are currently available to effectively treat PSP.  Anti-Parkinson’s medications are generally not as effective, although a small percentage of people respond moderately well to treatments with Levodopa.   An experienced doctor or neurologist should always be involved in managing any medication regime.

However, palliative medication can help greatly, for example muscle relaxants to help with cramps or gentle massaging of oils into limbs; the bathing of  eyes with cotton wool dipped in cooled boiled water to ease the extreme dryness of the eyes due to eyelid rigidity.  In Germany trials with CQ10 have also shown an efficacious benefit1.


Did you know?


PSP was first recognised by Dr J C Richardson in the 1950s after his best friend developed an unusual illness. This triggered Dr Richardson’s interest and research to help his friend.  He noticed that several more patients had similarly unusual symptoms.  He noted the progression of symptoms over a number of years and post-mortem examination revealed similar degeneration in each brain.  He reported his findings, together with Drs Steele and Olszewski, in 1964 and the name PSP became widely accepted for this disorder.  It is for this reason that PSP is sometimes referred to as Steele-Richardson-Olszewski syndrome.

 


References


  1. The PSP Association Position Statement on Coenzyme Q10 http://www.pspeur.org/care_and_support/position_statements/coenzyme_Q10/
EPDA EPDA EPDA EPDA EPDA EPDA EPDA EPDA